Mark Sivak

h-index

Research activity per year

Headline

PROFESSOR | Neurology

Fingerprint

Dive into the research topics where Mark Sivak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

19 Article
2 Chapter
2 Letter

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
Howard, J. F., Nowak, R. J., Wolfe, G. I., Freimer, M. L., Vu, T. H., Hinton, J. L., Benatar, M., Duda, P. W., MacDougall, J. E., Farzaneh-Far, R., Kaminski, H. J., Barohn, R., Dimachkie, M., Pasnoor, M., Farmakidis, C., Liu, T., Colgan, S., Bertorini, T., Pillai, R. & Henegar, R. & 54 others, Bromberg, M., Gibson, S., Janecki, T., Elsheikh, B., Matisak, P., Genge, A., Guidon, A., David, W., Habib, A. A., Mathew, V., Mozaffar, T., Hewitt, W., Barnett, D., Sullivan, P., Ho, D., Traub, R. E., Chopra, M., Aly, R., Bayat, E., Abu-Rub, M., Khan, S., Lange, D., Holzberg, S., Khatri, B., Lindman, E., Olapo, T., Sershon, L. M., Lisak, R. P., Bernitsas, E., Jia, K., Malik, R., Lewis-Collins, T. D., Nicolle, M., Sharma, A., Roy, B., Nye, J., Pulley, M., Berger, A., Shabbir, Y., Sachdev, A., Patterson, K., Siddiqi, Z., Sivak, M., Bratton, J., Small, G., Kohli, A., Fetter, M., Lam, L., Harvey, B., Silvestri, N., Patrick, K., Zakalik, K., Pontius, A. & Hoarty, M., May 2020, In: JAMA Neurology. 77, 5, p. 582-592 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
181 Scopus citations
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
MGTX Study Group, Mar 2019, In: The Lancet Neurology. 18, 3, p. 259-268 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
211 Scopus citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
REGAIN Study Group, 1 Dec 2017, In: The Lancet Neurology. 16, 12, p. 976-986 11 p.
Research output: Contribution to journal › Article › peer-review
714 Scopus citations
Analysis of laryngoscopic features in patients with unilateral vocal fold paresis
Woo, P., Parasher, A. K., Isseroff, T., Richards, A. & Sivak, M., 1 Aug 2016, In: Laryngoscope. 126, 8, p. 1831-1836 6 p.
Research output: Contribution to journal › Article › peer-review
18 Scopus citations
Interrater Reliability in Analysis of Laryngoscopic Features for Unilateral Vocal Fold Paresis
Isseroff, T. F., Parasher, A. K., Richards, A., Sivak, M. & Woo, P., 1 Nov 2016, In: Journal of Voice. 30, 6, p. 736-740 5 p.
Research output: Contribution to journal › Article › peer-review
14 Scopus citations

Mark Sivak

Personal profile

Headline

Fingerprint

Research output

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

Analysis of laryngoscopic features in patients with unilateral vocal fold paresis

Interrater Reliability in Analysis of Laryngoscopic Features for Unilateral Vocal Fold Paresis